
Eruptive porokeratosis during pembrolizumab treatment of invasive cutaneous squamous cell carcinoma.
Publication
, Journal Article
Maredia, H; Simkin, D; Soni, A; Loss, MJ
Published in: Int J Dermatol
May 2020
Duke Scholars
Published In
Int J Dermatol
DOI
EISSN
1365-4632
Publication Date
May 2020
Volume
59
Issue
5
Start / End Page
e141 / e142
Location
England
Related Subject Headings
- Treatment Outcome
- Skin Neoplasms
- Skin
- Porokeratosis
- Male
- Humans
- Fluorouracil
- Dermatology & Venereal Diseases
- Carcinoma, Squamous Cell
- Biopsy
Citation
APA
Chicago
ICMJE
MLA
NLM
Maredia, H., Simkin, D., Soni, A., & Loss, M. J. (2020). Eruptive porokeratosis during pembrolizumab treatment of invasive cutaneous squamous cell carcinoma. Int J Dermatol, 59(5), e141–e142. https://doi.org/10.1111/ijd.14701

Published In
Int J Dermatol
DOI
EISSN
1365-4632
Publication Date
May 2020
Volume
59
Issue
5
Start / End Page
e141 / e142
Location
England
Related Subject Headings
- Treatment Outcome
- Skin Neoplasms
- Skin
- Porokeratosis
- Male
- Humans
- Fluorouracil
- Dermatology & Venereal Diseases
- Carcinoma, Squamous Cell
- Biopsy